Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence increases during the menopausal transition, yet its interaction with obesity phenotypes in influencing cardiovascular disease (CVD) risk remains unclear. We examined how MASLD and obesity types are associated with CVD ris...
Dong Yun Kim, Kyu-Na Lee, Kyung-Do Han et al.· Biomedicines· 0 citations
BACKGROUND AND AIMS
Alcohol consumption is a well-established risk factor for HCC, though its impact may vary across different age groups. Accordingly, we aimed to investigate the association between alcohol consumption and the risk of HCC across different age groups.
METHODS
We included 4,234,445 participants aged ≥...
Mi Na Kim, Kyungdo Han, Dong Yun Kim et al.· JHEP Reports· 0 citations
Background: Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality in metabolic dysfunction–associated steatotic liver disease (MASLD). We investigated whether fibrosis severity assessed using guideline-recommended noninvasive liver fibrosis pathways was associated with incident ASCV...
Jaehong Jeong, J. Hong, Dong Yun Kim et al.· Hepatology Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.